(2-Dimethylaminoethyl)benzilat; Meerzwiebel, TE mit Ethanol/Ethanol-Wasser (%-Angaben); Phenyl(2-hydroxybenzoat); Petersilienwurzel, TE mit Wasser; Bärentraubenblätter, TE mit Wasser; Hauhechelwurzel, TE mit Ethanol/Ethanol-Wasser (%-Angaben); Orthosiphonblätter, TE mit Ethanol/Ethanol-Wasser (%-Angaben); Dibenzylbutandioat; Bukkoblätter, TE mit Ethanol/Ethanol-Wasser (%-Angaben); Birkenblätter, TE mit Ethanol/Ethanol-Wasser (%-Angaben) - Søgeresultater

USA - engelsk - NLM (National Library of Medicine)

orphenadrine citrate aspirin caffeine- orphenadrine citrate, aspirin, caffeine tablet

jerome stevens pharmaceuticals, inc. - orphenadrine citrate (unii: x0a40n8i4s) (orphenadrine - unii:al805o9og9), aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - - symptomatic relief of mild to moderate pain of acute musculoskeletal disorders. - the orphenadrine component is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions. the mode of action of orphenadrine has not been clearly identified, but may be related to its analgesic properties. these products do not directly relax tense skeletal muscles in man. because of the mild anticholinergic effect of orphenadrine, these products should not be used in patients with glaucoma, pyloric or duodenal obstruction, achalasia, prostatic hypertrophy or obstructions at the bladder neck. these products are also contraindicated in patients with myasthenia gravis and in patients known to be sensitive to aspirin or caffeine. the drug is contraindicated in patients who have demonstrated a previous hypersensitivity to the drug.